» Articles » PMID: 37671163

Cryoablation and Immunity in Non-small Cell Lung Cancer: a New Era of Cryo-immunotherapy

Overview
Journal Front Immunol
Date 2023 Sep 6
PMID 37671163
Authors
Affiliations
Soon will be listed here.
Abstract

Despite remarkable advances in tumor response and patient survival in the past decade, systemic immunotherapies for lung cancer result in an objective response in only around half of patients treated. On the basis of this limitation, combination strategies are being investigated to improve response rates. Cryoablation has been proposed as one such technique to induce immunogenic cell death and synergize with systemic immunotherapies, including immune checkpoint inhibitors. Cryoablation has been traditionally delivered percutaneously with imaging guidance although recent technological advances allow for bronchoscopic delivery. Herein, we review the pre-clinical and clinical evidence for the use of cryoablation in non-small cell lung cancer and potential induction of anti-tumor immunity. We highlight ongoing studies involving this approach and propose areas of future investigation.

Citing Articles

Early Effects of Bronchoscopic Cryotherapy in Metastatic Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Single-Center Prospective Study.

Vasiliauskas G, Zemaite E, Skrodeniene E, Poskiene L, Maziliauskiene G, Macionis A Diagnostics (Basel). 2025; 15(2.

PMID: 39857085 PMC: 11763732. DOI: 10.3390/diagnostics15020201.


A novel technique of cryodenervation for murine vagus nerve: implications for acute lung inflammation.

Wu D, Liao X, Gao J, Wang K, Xu W, Wang F Respir Res. 2025; 26(1):15.

PMID: 39806332 PMC: 11730848. DOI: 10.1186/s12931-025-03108-w.


CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC.

Desilets A, Pinheiro G, Belkaid W, Salko O, Malo J, Zarour E JTO Clin Res Rep. 2024; 5(12):100737.

PMID: 39624249 PMC: 11609556. DOI: 10.1016/j.jtocrr.2024.100737.


Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers: systemic review and meta-analysis.

Tan E, Chong J, Pua U, Tan E, Mok W Breast Cancer. 2024; 32(1):69-78.

PMID: 39425821 DOI: 10.1007/s12282-024-01643-w.


The Value of Magnetic Resonance Imaging in Assessing Immediate Efficacy After Microwave Ablation of Lung Malignancies.

Zhu F, Yang C, Wang J, Zhou T, Li Q, Wang S J Thorac Imaging. 2024; 39(6):392-398.

PMID: 39021208 PMC: 11495527. DOI: 10.1097/RTI.0000000000000797.


References
1.
Leppelmann K, Mooradian M, Ganguli S, Uppot R, Yamada K, Irani Z . Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis. J Vasc Interv Radiol. 2020; 32(2):187-195. DOI: 10.1016/j.jvir.2020.09.014. View

2.
Noppen M, Meysman M, Van Herreweghe R, Lamote J, Dhaese J, Vincken W . Bronchoscopic cryotherapy: preliminary experience. Acta Clin Belg. 2001; 56(2):73-7. DOI: 10.1179/acb.2001.013. View

3.
Baust J, Gage A, Bjerklund Johansen T, Baust J . Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology. 2013; 68(1):1-11. PMC: 3976170. DOI: 10.1016/j.cryobiol.2013.11.001. View

4.
Hinshaw J, Littrup P, Durick N, Leung W, Lee Jr F, Sampson L . Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol. 2010; 33(6):1180-5. PMC: 3155994. DOI: 10.1007/s00270-010-9868-0. View

5.
Ablin R, SOANES W, Bronson P, Gonder M . Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma. 1971; 18(3):271-6. View